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DCX labeled neurons and statistical differences were assessed by
repeated measures ANOVA.
Results: EE increased Ki-67 positive cells in WT mice and pre-
vented the occurrence of depressive-like behavior in YAC128 mice.
EE increased neuronal differentiation in both WT and YAC128 mice.
Dendritic arborization was also increased by EE exposure in WT
mice when compared to WT animals housed in standard housing
conditions.
Conclusion: Our results indicate that exposure to EE is able to
modulate hippocampal neuroplasticity in WT and YAC128 mice.
EE may have a potential therapeutic role in reversing the deficits in
neuroplasticity seen in HD.
https://doi.org/10.1016/j.ibror.2019.07.1500
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Expression of genes or proteins has been an important tool in
elucidating the neurochemical functioning underlying mood dis-
orders, especially in rodent models. The region-specificity of such
expressions has been largely acknowledged, but most of the stud-
ies consider these brain regions as a single functional unit, failing to
considerate hemispherical asymmetry that could alter the results
and their interpretation. The aim of this review is to verify the influ-
ence of cerebral laterality on the expression of genes or proteins
in reports investigating mood disorders in rodent models. Papers
studying mood disorders (depression or anxiety) that assessed the
gene or protein expression in the brain of rodents, measuring and
comparing this expression between the two hemispheres were
included. This study followed the PRISMA protocol. A search was
conducted on PubMed using keywords designed to retrieve papers
that met the inclusion criteria. Fifty-six articles were screened by
title and abstract and nine of them were eligible. Two papers were
excluded which resulted in the final seven papers. Data extraction
and analysis were conducted by two independent reviewers, with
a third resolving discrepancies. Results points to an asymmetrical
role of the main brain areas related with stress evoked disorders,
such as depression and anxiety, with neurotrophic factors and some
neurotransmitters receptors expression. Hemisphere asymmetry
factor was mainly studied in the prefrontal cortex, hippocam-
pus, amygdala, and olfactory bulb. Neurochemical parameters such
as GABAA receptor subunits, serotonin, dopamine and BDNF are
altered in an asymmetrical way. That dissimilarity is linked with
both the administration of substances and with animal models of
stress. One main question raised by this review is whether few
experimental protocols are designed to verify hemisphere differ-
ences or whether non-significant hemispherical analyses fail to
be published. We suggest that hemisphere differences should be
emphasized in further studies that explore psychiatric disorders.
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Alzheimer’s disease (AD) is the most common form of demen-
tia associated with an imbalanced production and clearance of
amyloid- peptides (A). Amyloid deposition and neuroinflamma-
tion are recognized hallmarks in AD, affecting mainly brain cortex
and hippocampus, in addition to microvascular alterations and
dysfunction of the blood-brain barrier (BBB). The glycan-binding
protein galectin-1 (Gal1) modulates immune and endothelial cells
in nervous system compartments, where a neuroprotective role
was proposed in autoimmune encephalomyelitis. We study the
impact of Gal1 on the cognitive and histopathological state of AD
mice. We administered Gal1 (9 i.p. injections of 100 ug/dose) or
vehicle during 3 weeks to 12 months-old PDAPPJ20 transgenic
mice, or non-transgenic controls. The Gal1 treated group signifi-
cantly improved cognitive response in the Novel Object Location
Recognition test (p < 0.05). Amyloid+ area in the hippocampus was
decreased by 53,5%. Microglia is actively involved in A phagocyto-
sis. Gal1 treatment induced a reduction in the microglial activation
score employing morphological analysis in the dentate gyrus. The
integrity of the BBB is essential to A clearance via the glymphatic
system but could be altered by perivascular A deposits-mostly
A1–40. Using tomato lectin to label the hippocampal vascula-
ture coupled with immunofluorescence against A peptides, we
found a 30% decrease of perivascular A (p < 0.05) in Gal1 treated
mice, without affecting vascular density, which could indicate aug-
mented clearance. We are currently working to determine mice
BBB integrity employing Evans Blue intravenous injections and
exploring its permeability to cerebral parenchyma, and using an
in vitro BBB model to determine whether A1–40 alters it at non
toxic concentrations. Human brain microvascular endothelial cells
on a transwell membrane are used, monitored by Transendothe-
lial Electrical Resistance (TEER) and permeability essays. We are
also investigating possible protective effects of Gal1 on barrier’s
integrity.
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